Natalie C. Holles - 25 Oct 2022 Form 4 Insider Report for Third Harmonic Bio, Inc. (THRD)

Role
CEO, Director
Signature
/s/ Natalie Holles
Issuer symbol
THRD
Transactions as of
25 Oct 2022
Net transactions value
$0
Form type
4
Filing time
27 Oct 2022, 16:52:45 UTC
Previous filing
14 Sep 2022
Next filing
08 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THRD Employee Option Grant (right to buy) Award $0 +205,000 $0.000000 205,000 25 Oct 2022 Common Stock 205,000 $18.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a 6-month period: 1/6th on October 25, 2022, after which 1/6th of the total shares vest monthly, subject to continued service through each vesting date.